Azoles are currently the mainstay of antifungal treatment both in agricultural and in clinical settings. Although the target site of azole action is well studied, the basis of azole resistance and the ultimate mode of action of the drug in fungi are poorly understood. To gain a deeper insight into these aspects of azole action, restriction-mediated plasmid integration (REMI) was used to create azole sensitive and resistant strains of the clinically important fungus Aspergillus fumigatus. Four azole sensitive insertions and four azole-resistant insertions were characterized. Three phenotypes could be re-created in wildtype AF210 by reintegration of rescued plasmid and a further four could be confirmed by complementation of the mutant phenotype with a copy of the wild-type gene predicted to be disrupted by the original insertional event. Six insertions were in genes not previously associated with azole sensitivity or resistance. Two insertions occur in transporter genes that may affect drug efflux, whereas others may affect transcriptional regulation of sterol biosynthesis genes and NADH metabolism in the mitochondrion. Two insertions are in genes of unknown function.
Introduction
Over the past few decades, the incidence of invasive aspergillosis has risen steadily. It is now the most common invasive mould infection worldwide (Denning, 1998; Latgé & Calderone, 2002; Denning et al., 2006) . At least 4% of all patients dying in tertiary care hospitals in Europe have invasive aspergillosis (Groll et al., 1996; Vogeser et al., 1999; Gomez-Lopez et al., 2003) . Mortality is almost 100% if the disease is left untreated and high (50 -100%) even with therapy (Denning, 1998) . Aspergillus fumigatus is usually the most common aetiologic agent, being responsible for up to 90% of human Aspergillus infections. As well as infecting humans, fungi may also cause diseases of plants and are one of the most important causes of crop loss in temperate regions (Oerke et al., 1994; Agrios, 1997; Oerke & Dehne, 2004) . Both human and agricultural diseases are treated with azole antifungals. These compounds target 14 sterol demethylase and interfere with ergosterol production in the fungus (Yoshida & Aoyama, 1984 , 1987 Wright et al., 1990) .
Recent testing of A. fumigatus clinical isolates has identified cases of azole resistance (Sanglard et al., 1995 (Sanglard et al., , 1997 Kelly et al., 1997; Nolte et al., 1997; Franz et al., 1998; Gupta et al., 1998; Schaller et al., 1998; Marichal et al., 1999; Calabrese et al., 2000; Moore et al., 2000; Yang & Lo, 2001; Verweij et al., 2002; Gomez-Lopez et al., 2003; Drago et al., 2004; Hsueh et al., 2005; Pfaller et al., 2006) some of which have been shown to be resistant to treatment with itraconazole (ITR) in murine models of infection (Denning et al., 1997a; Dannaoui et al., 1999 Dannaoui et al., , 2001 ). Long-term treatment for patients with ITR (Chryssanthou, 1997; Denning et al., 1997a; Dannaoui et al., 2001; Warris et al., 2002; Chen et al., 2005) appears to lead to azole resistance in infecting fungi, although these cases were not always associated with ITR treatment failure. Two per cent of 913 A. fumigatus isolates in the literature published before 2000 were found to be resistant (Dannaoui et al., 2001) . Recent surveys have reported frequencies ranging from 1% to 6% (total number of isolates surveyed was 357; Verweij et al., 2002; Gomez-Lopez et al., 2003; Drago et al., 2004; Hsueh et al., 2005) , although other surveys have reported no resistant isolates out of a total of 2100 isolates (Verweij et al., 1998; Chandrasekar et al., 2001; Diekema et al., 2003; Balajee et al., 2004; Dannaoui et al., 2004; Kauffmann-Lacroix et al., 2004; Guinea et al., 2005; Pfaller et al., 2005) . Recent estimates from our laboratory suggest higher levels of azole resistance (Howard et al., 2009) and similar studies in the Netherlands have also shown high levels of azole resistance.
A number of mutations in the cyp51A lanosterol 14a-demethylase gene have been associated with azole resistance (Denning et al., 1997a; Diaz-Guerra et al., 2003 Ferreira et al., 2004; Mellado et al., 2004 Mellado et al., , 2005 Chen et al., 2005) . Other mechanisms for azole resistance include increased expression of efflux pumps. The increased expression of an ATP-binding cassette (ABC) transporter (AtrF) in the presence of ITR has been shown in a clinical isolate with reduced drug accumulation (Slaven et al., 2002) , and possible transporters have been implicated in azole resistance of laboratory selected mutants (Denning et al., 1997a; Nascimento et al., 2003; Ferreira et al., 2004) .
Restriction enzyme-mediated integration (REMI) was employed, as it increases the transformation efficiency and promotes single-copy, non-rearranged integrations of the transforming DNA (Lu et al., 1994; Bolker et al., 1995; Brown et al., 1998; de Souza et al., 2000) . This technique has been employed as a means of generating tagged insertional mutants in a variety of organisms (Lu et al., 1994; Bolker et al., 1995; de Souza et al., 2000) . REMI has previously been used in Aspergillus (Brown et al., 1998; Sánchez et al., 1998) to identify genes required for in vivo growth or normal morphology. Osherov et al. (2001) used an overexpression approach to isolate genes that give resistance to ITR in Aspergillus nidulans but only identified the P-450 14 aDM gene, pdmA, as a mechanism of resistance. de Souza et al. (2000) screened 1354 REMI insertional mutants to study azole resistance in A. nidulans of which 33 displayed sensitivity to ITR; however, no molecular analysis of insertion sites was performed.
In this study, we employed a restriction enzymemediated integration (REMI)-tagged insertional mutagenesis screen to identify transformants with increased ITR susceptibility in A. fumigatus. As fungi display a basal resistance to azoles, we also screened for isolates that were more susceptible to azoles as in this case inactivated genes would be involved in azole toxicity.
Materials and methods

Strains, plasmids and chemicals
Aspergillus fumigatus clinical isolate AF210 (NCPF 7101) is susceptible to ITR and amphotericin B (Denning et al., 1997b . Two hundred micrograms XhoI linearised pPyrG was added to 4 mL of protoplasts, followed by 160 U of XhoI and 2 mL of 0.05 M CaCl 2 , 0.6 M KCl, 0.01 M Tris-Cl (pH 7.5), 40% PEG 4000, and mixed. After incubation on ice for 20 min, a further 40 mL of this buffer was added and mixed, followed by an additional 15 min incubation at room temperature. Six millilitres of the transformation mixture was then added to a liquid layer of 4 mL of RPMI containing 2% glucose, Vogel's salts, 0.6 M KCl, penicillin (100 U) and streptomycin (100 ng mL À1 ) on top of 9 cm RPMI agar plates containing 2% glucose and Vogel's salts, incubated at 37°C. For transformations with the plasmids obtained by plasmid rescue, 20 times smaller volumes were used. Each plasmid was digested with the restriction enzyme that had been used for the plasmid rescue (XhoI or ClaI).
ITR susceptibility screening and azole MIC testing
After 24-48 h at 37°C, plates containing putative transformed colonies were overlayed with 4 mg L À1 ITR in RPMI, 1% agar. After 48 h, a differentiable new ring of growth was observable. The colonies that had a bigger or smaller ring than the majority were checked for their susceptibility to ITR by inoculating spores onto RPMI plates containing 2% glucose and 2% agar and containing either 0.50, 0.25 or 0.12 mg L À1 ITR. Mutants with ITR susceptibilities clearly different from the parental isolate were subsequently tested for their MICs to four azoles (Table 1; Denning et al., 1997b) . The MICs were read visually and were defined as the lowest drug concentration with no visible growth.
Fungal DNA extraction, PCR and Southern hybridisation
Fungal DNA was isolated using the DNeasy Plant Mini Kit (Qiagen, Crawley, UK). The presence of the integrated pPyrG plasmid was confirmed by PCR using primers Cf and Gr directed against the Amp R gene (Supporting information, Table S1 ).
Genomic DNA (3 lg) was digested to completion with XhoI, ClaI or NcoI, as appropriate, separated in 0.8% agarose, transferred onto a positively charged nylon membrane (Roche Diagnostics, Lewes, UK) and hybridised overnight at 42°C in DIG Easy Hyb (Roche) with a DIG-labelled probe consisting of the pUC19 DNA or the HindIII fragment of the pPyrG plasmid. Washing was carried out at 65°C in 0.59 SSC, 0.1% SDS with stringent washing using 0.19 SSC, 0.1% SDS.
Plasmid rescue and sequencing
Plasmid rescue was carried out by digesting genomic DNA with XhoI or ClaI, separating the DNA in 0.8% agarose and purifying DNA of ± 1-2 kb of the estimated size according to the Southern hybridisations. DNA was ligated overnight at 16°C with T4 DNA ligase and electroporated into Escherichia coli DH5a (Invitrogen, Paisley, UK) or SCS110 (Stratagene, Amsterdam, the Netherlands). The sequence flanking the pPyrG insertion site was determined using primers FOR and REV, which hybridised 68 bp upstream and 88 bp downstream of the A. nidulans pyrG XhoI site, respectively.
Construction of clones for mutant complementation
Regions including~1 kb upstream and 1 kb downstream of AFUA_5G07550, AFUA_2G11840, AFUA_2G11020, AFUA_4G10880 and AFUA_6G12570 were amplified by PCR using primers 5G07550F and 5G07550R, 2G11840F and 2G11840R, 2G11020F and 2G11020 R, 4G10880F and 4G10880R, and 6G12570F and R.
Fifty microlitres PCR contained 25 lL 23 Phusion mastermix, 40 pM primers and 200 ng Af293 DNA according to the manufacturer's instructions (New England Biolabs) and were subjected to 35 cycles at 96°C for 15 s, 58°C for 5 min and 72°C for 80 s followed by an extension step at 72°C for 5 min. Products were assessed by gel electrophoresis, gel purified using a Qiaex kit (Qiagen) and then cloned into pGEM-T (Promega). Plasmids were termed p5G07550, p2G11840, p2G11020, p4G10880 and p6G12570, and cotransformed into REMI strains as appropriate using 3 lg pAN7-1 as cotransforming plasmid with selection on 150 lg mL À1 hygromycin.
Computer analyses
Sequences were compared to A. fumigatus Af293 genomic sequence (Nierman et al., 2005) using the BLAST function on the CADRE database (Mabey Gilsenan et al., 2009) . Both flanking regions were located in the genomic sequence and used to pinpoint the insertion site.
Growth experiments
Colony radial growth experiments were carried out as described previously (Robson et al., 1995) using 2% glucose in agar plates containing Vogel's salts.
Results
Isolation and characterisation of tagged insertional mutants
Four thousand transformants were isolated and screened for altered susceptibility to ITR. After overlay with ITR containing agar, 19 transformants that displayed either continued or completely arrested growth were selected, of which eight had at least a fourfold difference in ITR susceptibility relative to the parental strain (Table 2 ). All eight transformants displayed normal growth rate colony morphology and sporulation compared to the parental strain. These eight transformants were selected for further analysis. 
Analysis of REMI events
The eight transformants (termed REMI-11, REMI-14D, REMI-56, REMI-85, REMI-101, REMI-102, REMI-103 and REMI-116) were characterised further to determine the nature of the REMI insertion. PCR using primers directed against the Amp R gene in pUC19 confirmed that all of them had at least one integrated copy of pPyrG. Restriction digestion followed by Southern hybridisation with the pUC19 vector fragment of pPyrG was carried out to determine the nature of the plasmid integrations. XhoI digests established whether or not 'perfect' REMI that retained the XhoI sequence at the site of insertion had occurred: a single 4.8 kb hybridising band, which represents pPyrG, indicated such an event (Fig. 1) . REMI-11, REMI-56 and REMI-101 all give 4.8 kb bands expected from a single insertion. REMI-85, REMI-14D, REMI-103 and REMI-102 give single bands larger than 4.8 kb and REMI-116 gives two bands. This data were combined with sequence from the insertion site and flanking regions to determine whether the REMI event had occurred at a genomic XhoI site. In REMI-85, REMI-14D, REMI-102, REMI-104 and REMI-116, the rescued plasmids had partial XhoI sites flanking the insertion suggesting that integration occurred in an imperfect manner. REMI-11, REMI-56 and REMI-101 all contained intact XhoI sites at the insertional locus. Combining the Southern blot data and the flanking sequence, we were able to categorise the REMI insertion into perfect or imperfect (Table 2) and determine the insertional copy number. 7/8 RMI isolates had one single plasmid insertion in the genome, three which were perfect REMI. One of them, REMI-116, had multiple insertions and was not investigated further.
The site of plasmid insertion was successfully determined by plasmid rescue in all REMI transformants. The rescued genomic sequence on either side of the insertion was determined by plasmid sequencing and used to identify the locus of insertion by comparison with the Af293 genome.
Analysis of REMI insertion sites
Rescued plasmids were sequenced and analysed by restriction digestion to define the site of insertion in the genome. Insertion sites are shown in the cartoon in Fig. 2 .
In REMI-11, the insertion had occurred at a XhoI site 1820 bp downstream from the start codon of an ABC transporter family gene (AFUA_1G14330) and within the coding region. REMI-56 is an insertion upstream of a major facilitator superfamily (MFS) transporter. The insertional mutation has occurred in the 619 bp intergenic REMI-102 was determined to contain an insertion in the promoter region of the A. fumigatus cyc8 gene orthologue (AFUA_2G11840). The final REMI strain (REMI-116) was shown to have an insertion in the epsin 2 gene (AFUA_6G12570). However, Southern blot analysis suggests that there are at least two insertional events in this strain, and attempts to re-create the phenotype were unsuccessful. Therefore, it seems likely that the insertion in the epsin2 gene and the observed phenotype may be unlinked.
Confirmation of the association between plasmid insertion and observed phenotype
As uncharacterised secondary mutations may arise during transformation or REMI, rescued plasmids were used to re-create the azole-resistant phenotype in the parental strain. Because the rescued plasmids contain flanking regions of the original insertion site, this procedure is functionally analogous to commonly used allele replacement methods and recombination between flanking regions and genomic DNA should regenerate the original REMI insertion in a new wild-type or parental strain (Fig. S1 ).
Plasmids were termed p11, p85 etc., according to the REMI number of the parental isolate and were successfully rescued for all eight REMI strains. Flanking regions of genomic DNA in the rescued plasmids were mapped to genes by sequencing. The regions rescued are shown in Fig. 2 . When AF210.1 was retransformed with p11, p56 and p101, the phenotype of the original REMI-11, REMI-56 and REMI-101 strains was reconstituted. Frequency of reconstruction of REMI insertions was 1 in 380 transformants for p11, 2 in 870 for p56 and 4 in 40 for p101. These transformants had the same azole susceptibilities as the original REMI strains. A Southern hybridisation carried out on genomic DNA isolated from these transformants confirmed that they had the same hybridisation pattern as the original transformants, indicating that the insertion had occurred at the same parts in the genome (Fig. 3) . We note that for retransformation of AF210 with p56, aberrant band sizes were obtained on a Southern blot after XhoI digestion, although the expected sizes were obtained after ClaI digestion. We are unable to explain this banding pattern, and REMI-56 was therefore included in the complementation experiments described later. The plasmids used for the other reconstruction experiments lacked long flanking sequences on one side of the insertion and it is possible that the double recombination event required for reconstitution of the REMI was inefficient. A high number of transformants was tested in these cases (670 for p102, 3200 for p85, 540 for p14D and 420 for p103). To determine whether phenotype and insertion were linked, it was decided to attempt to complement the mutations using genes amplified by PCR from Af293. Plasmids p5G07550, p1G05010, p2G11840, p2G11020, p4G10880 and p6G12570 were cotransformed into REMI-85, REMI-56 REMI-102, REMI-14D, REMI-103 and REMI-116, respectively. Wild-type (AF210) or parental (AF210.1) levels of azole resistance were obtained from all transformations except that of REMI-116 (Table 3) . Primers flanking the original insertion site were used to confirm that intact copies of complementing genes were present in strains where wild-type phenotypes had been restored. In all cases, restoration of parental AF210.1 phenotype as assessed by MIC ITR corresponded to integration of an intact genomic copy of the appropriate gene.
Discussion
In this study, we aimed to discover new genes and mechanisms involved in ITR resistance in A. fumigatus. Several insertional mutants were isolated from a REMI screen and characterised. Eight of 4000 mutants tested displayed altered azole sensitivity with four mutants showing increased sensitivity and four showing decreased sensitivity.
Two putative transporter genes were isolated in the screen as being involved in resistance to azoles (i.e. the insertions were more sensitive to azoles). One gene identified is an ABC transporter and is probably an orthologue of the A. nidulans AtrG and Pmr1 of Penicillium digitatum (Nakaune et al., 1998) . Overexpression of multidrug resistance (MDR) efflux transporter genes of the ABC and the MFS classes is thought to play an important role in azole resistance in Aspergillus. In Candida albicans, ABC transporter genes CDR1 and CDR2, and major facilitator efflux gene MDR1 have been shown to be involved in azole resistance (Sanglard et al., 1995 (Sanglard et al., , 1997 Gupta et al., 1998; Calabrese et al., 2000) . The A. fumigatus Three micrograms of genomic DNA was digested overnight at 37°C with 20 U XhoI (a) or 20 U ClaI (b), then run on an 0.8% agarose gel before blotting and probing with DIG-labelled HindIII digested pPyrG DNA. In cases where the retransformation results in recreation of the REMI insertion, the size of the retransformant band should correlate with that obtained in the parental REMI strain. These appear correct for REMI-11 and REMI-101 retransformants; however, the REMI-56 transformant and retransformants give aberrant bands for the XhoI digestion. Azole resistance in Aspergillus orthologue of C. albicans CDR1 is AFUA_1G14330, the site of the insertion in REMI-11. Insertional inactivation of this protein would therefore be expected to lead to azole sensitivity. The REMI-56 insertion is upstream of a putative MFS transporter (AFUA_1G05010). The closest C. albicans MDR1 orthologue in A. fumigatus is AFUA_2G16860 annotated as an MFS transporter, BLAST search of the A. fumigatus sequence with MDR1 does not identify AFUA_1G05010 (BLAST cut-off score of 30, E value of 0.1). Comparison of AFUA_1G05010 with the C. albicans genome reveals similarity to XP_716751, one of a family of related potential transporter genes (XP_719316.1, XP_716470.1, XP_715705.1, XP_723465.1, XP_723276.1, XP_709949.1 and XP_712988.1) similar to Saccharomyces cerevisiae YKR105C, YCL069W, SGE1 (YPR198W) and AZR2 (YGR224W) MFS-MDR proteins involved in resistance to mutagens. The association of this class of MDR protein with azole resistance has not previously been reported. Given that the insertion in REMI-56 is in the promoter region of AFUA_1G05010, there is a formal possibility that the gene is overexpressed rather than down regulated. In this case, the gene might be involved in azole uptake.
One insertion leading to azole sensitivity was found in the A. fumigatus cyc8 orthologue (AFUA_2G11840). If this protein is involved in repression of ergosterol biosynthesis in a manner similar to that observed in S. cerevisiae (Henry et al., 2002; Kwast et al., 2002) then insertional inactivation could lead to activation of the ergosterol biosynthetic pathway. This may lead to azole resistance by increasing the levels of the target protein (Dannaoui et al., 2001) .
Two genes were identified where insertional mutagenesis resulted in an increase in azole resistance. This implies that these genes act to confer azole sensitivity in the wildtype isolate. These genes have never been associated with azole action and are at first sight unrelated. The first gene, a component of complex I of respiration is well studied in the context of complex I activity and activation in Neurospora crassa and appears to be involved in a switch between active and less active forms of the complex (Videira & Duarte, 2002; Marques et al., 2005; Ushakova et al., 2005) . This suggests that regulation of the enzymic activity of complex I may play an important role in azole action, although the nature of this role remains to be determined. The second gene, triose phosphate isomerase, is also well studied as a model enzyme and encodes a glycolytic enzyme (Cui & Karplus, 2003) . The insertional mutants from this REMI screen have no obvious aberrant phenotype and it appears that these two genes are dispensable for normal growth. The function of these genes may be linked or separate in their role in azole sensitivity, but we suggest that the simplest explanation is that they may function in a related manner. One potential link between these two genes is that a substrate for triose phosphate isomerase is dihydroxy acetone phosphate. This compound is part of the glycerol phosphate shuttle (Rigoulet et al., 2004) that regenerates NADH inside the mitochondrion, as cytoplasmically derived NADH is unable to pass into this organelle. Thus, these two seemingly disparate genes may be linked by utilisation and supply of NADH in the mitochondrion with the possibility that susceptibility to azoles functions via mitochondrial NADH metabolism or NAD/NADH redox stress. One issue raised by the involvement of complex I in azole sensitivity is the value of S. cerevisiae as a model system for study of azoles as this organism lacks a functional complex I. Fig. S1 . Confirmation of gene-insertion -phenotype correlation by plasmid rescue and retransformation. Table S1 . Primers used in this study.
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